Surgical Treatment for Hilar Cholangiocarcinoma (Klatskin-tumor);Chirurgische Therapie Hilärer Gallengangskarzinome (Klatskin-Tumoren)

Zentralblatt fur Chirurgie

Volumn 128, Issue 11, 2003, Pages 928-935

  Becker, T ^a   Lehner, F ^a   Bektas, H ^a   Meyer, A ^a   Luck R ^a   Nashan, B ^a   Klempnauer, J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Hilar cholangiocarcinoma; Klatskin tumor; Long term survival; Prognosis; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

BILE DUCT CARCINOMA; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; DIAGNOSTIC TEST; ENDOSCOPY; HISTOPATHOLOGY; HUMAN; KLATSKIN TUMOR; LIVER RESECTION; LIVER TRANSPLANTATION; MORBIDITY; PHOTODYNAMIC THERAPY; PREOPERATIVE EVALUATION; REVIEW; STENT; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; DATA INTERPRETATION, STATISTICAL; FEMALE; HEPATIC DUCT, COMMON; HUMANS; KLATSKIN'S TUMOR; MALE; MIDDLE AGED; PALLIATIVE CARE; PROGNOSIS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0344983737     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44800     Document Type: Review

References (40)

1. Alessiani M, Tzakis A, Todo S, Demetris AJ, Fung JJ, Starzl TE. Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg 1995; 180: 1-9
2. Altemeier WA, Gall EA, Zinninger MM, Hoxworth PI. Sclerosing carcinoma of the major intrahepatic bile ducts. Arch Surg 1957; 75: 450-461
3. Baer HU, Stain SC, Dennison AR, Eggers B, Blumgart LH. Improvements in survival by aggressive resections of hilar cholangiocarcinoma. Ann Surg 1993; 217: 20-26
4. Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzen H, Almer S, Granath F, Broome U. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002; 36: 321-327
5. Berr F, Wiedmann M, Tannapfel A, Halm U, Kohlhaw KR, Schmidt F, Wittekind C, Hauss J, Mossner J. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. J Hepatology 2000; 31: 291-298
6. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215: 31-38
7. Boerma EJ. Research into the results results of resection of hilar bile duct cancer. Surgery 1990; 108: 572-580
8. Brown G, Myers M. The hepatic ducts. A surgical approach for resection of tumours. Aust N Z J Surg 1954; 23: 308-312
9. De Vreede I, Steers JL, Burch PA, Rosen CB, Gunderson LL, Haddock MG, Burgart L, Gores GJ. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000; 6: 309-316
10. Iwatsuki S, Todo S, Marsh JW, Madariaga JR, Lee RG, Dvorchik I, Fung JJ, Starzl TE. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998; 187: 358-364
11. Kaczynski J, Hansson G, Wallerstedt S. Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area. Br J Cancer 1996; 73: 128-132
12. Kang YK, Kim WH, Jang JJ. Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. Hum Pathol 2002; 33: 877-883
13. Kawarada Y, Isaji S, Taoka H, Tabata M, Das BC, Yokoi H. S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract. J Gastrointest Surg 1999; 3: 369-373
14. Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Nimura Y. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001; 233: 385-392
15. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An Unsual tumor with distinctive clinical and pathological features. Am J Med 1965; 38: 241-256
16. Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr RJ. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. Clin Oncol 1997; 15: 947-954
17. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230: 663-671
18. Launois B, Terblanche J, Lakehal M, Catheline JM, Bardaxoglou E, Landen S, Campion JP, Sutherland F, Meunier B. Proximal bile duct cancer: high resectability rate and 5-year-survival. Ann Surg 1999; 230: 266-275
19. Makuuchi M, Kosuge T, Lygidakis NJ. New possibilities for major liver surgery in patients with Klatskin tumors or primary hepatocellular carcinoma - an old problem revisited. Hepatogastroenterology 1991; 38: 329-336
20. Mizumoto R, Suzuki H. Surgical anatomy of the hepatic hilum with special reference to the caudate lobe. World J Surg 1988; 12: 2-10
21. Nagino M, Nimura Y, Kamiya J, Kanai M, Uesaka K, Hayakawa N, Yamamoto H, Kondo S, Nishio H. Segmental liver resections for hilar cholangiocarcinoma. Hepatogastroenterology 1998; 45: 7-13
22. Nagino M, Kamiya J, Kanai M, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Nimura Y. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery 2000; 127: 155-160
23. Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Kanai M, Nimura Y. Complications of hepatectomy for hilar cholangiocarcinoma. World J Surg 2001; 25: 1277-1283
24. Nashan B, Schlitt HJ, Tusch G et al. Biliary malignacies in primary sclerosing cholangitis: Timing for liver transplantation. Hepatology 1996; 23: 1105-1111
25. Neuhaus P, Blumhardt G. Extended bile duct resection - a new oncological approach to the treatment of central bile duct carcinomas? Description of method and early results. Langenbecks Arch Chir 1994; 379: 123-128
26. Neuhaus P, Jonas S. Surgery for hilar cholangiocarcinoma - the German experience. J Hepatobiliary Pancreat Surg 2000; 7: 142-147
27. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 1990; 14: 535-543
28. Nimura Y, Kamiya J, Nagino M, Kanai M, Uesaka K, Kondo S, Hayakawa N. Aggressive surgical treatment of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 1998; 5: 52-61
29. Nimura Y, Kamiya J, Kondo S, Nagino M, Uesaka K, Oda K, Sano T, Yamamoto H, Hayakawa N. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 2000; 7: 155-162
30. Ogura Y, Mizumoto R, Tabata M, Matsuda S, Kusuda T. Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas. World J Surg 1993; 17: 85-92
31. Ogura Y, Kawarada Y. Surgical strategies for carcinoma of the hepatic duct confluence. Br J Surg 1998; 85: 20-24
32. Pichlmayr R, Lehr L, Ziegler H. Resection of juxtahilar bile duct carcinoma instead of palliative drainage of the biliary tract. Langenbecks Arch Chir 1983; 359: 275-288
33. Pichlmayr R, Weimann A, Ringe B. Indications for liver transplantation in hepatobiliary malignancy. Hepatology 1994; 20: 33S-40S
34. Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Maschek H, Tusch G, Ringe B. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996; 224: 628-638
35. StarzI TE, Todo S, Tzakis A, Podesta L, Mieles L, Demetris A, Teperman L, Selby R. Stevenson W, Stieber A et al. Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 1989; 210: 374-385
36. Tannapfel A, Benicke M, Katalinic A, Uhlmann D, Kockerling F, Hauss J, Wittekind C. Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut 2000; 47: 721-727
37. Todoroki T, Kawamoto T, Koike N, Takahashi H, Yoshida S, Kashiwagi H, Takada Y, Otsuka M, Fukao K. Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg 2000; 87: 306-313
38. Tsuzuki T, Ueda M, Kuramochi S, Iida S, Takahashi S, Iri H. Carcinoma of the main hepatic duct junction: indications, operative morbidity and mortality, and long term survival. Surgery 1990; 108: 495-501
39. Vogl TJ, Balzer JO, Dette K, Hintze R, Pegios W, Maurer J, Keck H, Neuhaus P, Felix R. Initially unresectable hilar cholangiocarcinoma: hepatic regeneration after transarterial embolization. Radiology 1998; 208: 217-222
40. Washburn WK, Lewis WO, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 1995; 130: 270-276